Health and Medical News - Page 43

Page 43 of Health and Medical News issued by the Send2Press® Newswire service.



Rexin-G(TM), The World’s First Tumor-Targeted Gene Therapy Vector, Stymies Metastatic Cancer

SAN MARINO, Calif. and MANILA, Philippines – Nov. 6 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies today announced the publication of clinical data from studies conducted at the University of the Philippines, Asian Hospital and Medical Center, Makati Medical Center, Manila, Philippines and Lutheran Medical Center, New York, USA, revealing the safety and single agent efficacy of Rexin-G(TM) for the treatment of a broad spectrum of chemotherapy-resistant cancers.

Las Vegas Infertility Specialist Reports Improved Pregnancy Rates for In Vitro Fertilization (IVF) Using 4-Dimensional, Ultrasound-Guided Embryo Transfer

NEW ORLEANS, La. – Nov. 3, 2006 (SEND2PRESS NEWSWIRE) — An advance in uterine visualization during embryo transfer was reported to improve pregnancy rates for patients undergoing In Vitro Fertilization. The preliminary findings of an ongoing study were reported today at the 62nd annual meeting of the American Society for Reproductive Medicine in New Orleans, LA. Dr. Jeffrey D. Fisch, of the Sher Institute for Reproductive Medicine(SM), Las Vegas, NV (SIRM(tm)-Las Vegas) presented data evaluating the use of 4D ultrasound-guidance during embryo transfer.

MyHearPod Introduces an Amazingly Small Hearing Aid called HP Micro

CORNELIUS, N.C. – Nov. 1 (SEND2PRESS NEWSWIRE) — HearPod Hearing Aids president Randy Wohlers, BC-HIS, announced today the introduction of the HearPod Micro, which is one of the smallest completely in the canal (CIC) hearing aids on the market and designed to be used for open fittings. Open fitting means the hearing aid allows venting for equalization of pressure inside the ear canal.

Los Angeles Infertility Center Recruiting Patients for In Vitro Fertilization (IVF) Study Offering Free Medications

LOS ANGELES, Calif. – Oct. 30 (SEND2PRESS NEWSWIRE) — The Sher Institute for Reproductive Medicine(SM) (SIRM(TM)) in Los Angeles is currently recruiting patients to take part in a study that examines the effect of specific medical protocols in women who are considered ‘poor responders’ to fertility medications. Patients who meet the qualification criteria and are selected to take part in the study will be eligible to receive up to $6,000 worth of free medications as part of their treatment.

Dallas Infertility Center Celebrates First IVF Babies

DALLAS, Texas – Oct. 27 (SEND2PRESS NEWSWIRE) — The Sher Institute for Reproductive Medicine(SM) in Dallas (SIRM(TM)-Dallas) celebrated a milestone earlier this month as the first babies conceived through In Vitro Fertilization in its office were born. On October 2rd, Dallas residents Ellen and Barry Ford welcomed Jake and Emma – twins conceived with the help of Dr. Walid Saleh at SIRM-Dallas.

MediQuin Announces New Service that Increases Medical Practice Profitability and Productivity

LOS ANGELES, Calif. – Oct. 26 (SEND2PRESS NEWSWIRE) — MediQuin Credentialing Services, Inc. currently serves the medical community by providing credentialing and automated-application processing. By outsourcing, the company allows their clients to focus on successfully growing their practices.

A Step Ahead of Resistance; Virco introduces an Improved Rapid Methodology to Establish New HIV-1 Resistance Profiles

MECHELEN, Belgium – Oct. 16 (SEND2PRESS NEWSWIRE) — Responding to the need to make timely evaluations and decisions when treating treatment experienced HIV patients, Virco, a leader in drug resistance testing recently introduced an improved virco(R)TYPE HIV-1 test that rapidly determines the complex phenotypic resistance profiles for darunavir, tipranavir and other antiretroviral (ARV) drugs.

Epeius Biotechnologies Affirms Leadership Role in The Development of Genetic Medicine

SAN MARINO, Calif. – Oct. 11 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation today announced that Dr. Frederick Hall, President and CEO of Epeius Biotechnologies, has accepted an invitation to speak at the upcoming Global Pharmaceutical Research & Development Summit held on Oct. 24 at 4:10 p.m. (PT) in Anaheim, Calif. Dr. Hall will present the current status of global development and the broad pharmaceutical indications for the company’s innovative targeting technology platform that has enabled Epeius to develop Rexin-G(TM).

Guidance from Doctors on Long Term Care Insurance; Information to Be Available in Waiting Rooms

KIRKLAND, Wash. – Sept. 27 (SEND2PRESS NEWSWIRE) — In a doctor’s office near you, look for facts on a matter of growing concern, long term care insurance. Starting today, informative waiting room displays are being supplied to physicians by LTC Financial Partners LLC, the nation’s most experienced long term care insurance brokerage.

Innovative Physicians Offer a Better Way for Walk-In Urgent Care

ARLINGTON HEIGHTS, Ill. – Sept. 21 (SEND2PRESS NEWSWIRE) — Greater Northwest Medical Group, a leading internal medicine and family practice medical group established in 1984, with offices in Arlington Heights, Buffalo Grove, and Glenview, offers their patients a safe, effective, and comfortable alternative to walk-in urgent care treatment clinics.

Los Angeles Infertility Practice Welcomes New Physician

LOS ANGELES, Calif. – Sept. 15 (SEND2PRESS NEWSWIRE) — The Sher Institute for Reproductive Medicine(SM) – Los Angeles (SIRM(TM)-LA) is proud to announce the appointment of Dr. Rudy Quintero as an Associate Medical Director of the practice. A graduate of the UCLA School of Medicine, Dr. Quintero completed his residency at Glendale Adventist Hospital and a fellowship in Reproductive Endocrinology and Infertility at Stanford University Medical Center.

New Sher Institute IVF Office in Monmouth County to Offer Exclusive Access to Breakthrough Technology

SHREWSBURY, N.J. – Sept. 15 (SEND2PRESS NEWSWIRE) — The Sher Institute for Reproductive Medicine(SM)-New Jersey (SIRM(TM)-NJ), part of one of the largest and fastest growing infertility networks in the United States, announces the opening of a new office in Monmouth County. Located in Shrewsbury, New Jersey, the office will have exclusive access in the area to various SIRM(TM) breakthrough technologies in the field of In Vitro Fertilization (IVF) that have the potential to dramatically increase the odds of a woman getting pregnant through IVF, while at the same time reducing the likelihood of multiple births.

Cyberonics CEO to Keynote 2006 Neurotech Leaders Forum

SAN FRANCISCO, Calif. – Sept. 14 (SEND2PRESS NEWSWIRE) — Robert P. ‘Skip’ Cummins, chairman and CEO of Cyberonics Inc., will keynote the 2006 Neurotech Leaders Forum, to be held September 28-29, 2006 at the Crowne Plaza San Francisco International Airport. The free-speaking neurotechnology industry pioneer will share some of his experiences dealing with regulatory, technical, and marketing issues during his tenure at Cyberonics. Several other neurotechnology leaders will contribute during the conference.

Top Hearing Health Care Professionals Learn Benefits of an Evidence-Based Practice

HONOLULU, Hawaii – Sept. 14 (SEND2PRESS NEWSWIRE) — Family Hearing Center’s Randy Wohlers, a 30-year Hearing Health Care veteran, addressed a group of hearing health professionals in Vail, Colorado about ‘Evidence-Based Practice,’ and why it makes Family Hearing Center unique.

Family Hearing Aid Center Sets New Standards for Hearing-Aid Practices

HONOLULU, Hawaii – Aug. 23 (SEND2PRESS NEWSWIRE) — The focus of the Family Hearing Aid Center is to rehabilitate patients using an evidence based practice that provides clinically-measured proof of hearing help.

‘Soundly Sleeping’ is an Easy to Learn Alternative to Sleep Medication with No Side Effects and is Based on Proven Results

BEVERLY HILLS, CA – Aug. 17 (SEND2PRESS NEWSWIRE) — Dr. Joel L. Becker, Director of Cognitive Behavior Associates and Assistant Clinical Professor at the Geffen School of Medicine at UCLA, has announced the inauguration of a new interactive sleep program. Consumers and physicians are both concerned about the side effects of sleep medications and patient’s growing dependence on them. Aggressive marketing by the drug companies for sleep medications led to Dr. Becker’s decision to present an alternative to the patient that has better results and no side effects.

HearPod, Inc. Leads the Way in Digital Hearing-Aid Technology and Comfortable Design at Affordable Prices

CORNELIUS, NC – Aug. 2 (SEND2PRESS NEWSWIRE) — HearPod hearing-aid solutions were developed by baby boomers for baby boomers to resolve mild to moderate and high-frequency hearing loss. A uniquely-designed silicone pillow has allowed the manufacturers of HearPod hearing aids to have an incredible edge for dispensing high-end digital hearing aids for hearing-loss treatment.

New Sher Institute IVF Office on Long Island to Have Exclusive Access to Breakthrough Technology

GARDEN CITY, NY – July 10 (SEND2PRESS NEWSWIRE) — The Sher Institute for Reproductive Medicine – New York, part of one of the largest and fastest growing infertility networks in the United States, announces the opening of Sher Institute for Reproductive Medicine-Long Island (SIRM(SM)-Long Island) in partnership with Dr. Jeffrey Braverman.

Sacramento Infertility Practice Earns Prestigious Medical Accreditation

SACRAMENTO, CA – July 7 (SEND2PRESS NEWSWIRE) — The Sher Institute for Reproductive Medicine in Sacramento (SIRM(SM)-Sacramento) was recently awarded full accreditation by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and received the commission’s Gold Seal of Approval(TM).

Epeius Biotechnologies Initiates Tri-REX Vaccination Protocols for Breast Cancer

SAN MARINO, CA and MANILA, Philippines – July 5 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies today announced the opening of a Vaccine-assisted Phase I/II clinical trial for metastatic breast cancer that is refractory to conventional chemotherapy. The innovative protocol introduces Reximmune-C(TM), the second in a series of targeted biologic therapies designed to seek out, accumulate in, and destroy metastatic tumor nodules, while sparing normal cells and tissues.

New Hope in the Global Fight Against Malaria

OJAI, CA – June 22 (SEND2PRESS NEWSWIRE) — Global Resource Alliance (GRA), a California-based non-profit, announced today results of an on-going study in the Lake Victoria Region of Tanzania which suggests that a homeopathic neem tincture is both highly effective and financially feasible for the treatment and prevention of malaria (plasmodium falciparum). Eighty-one percent of participants in the study reported a significant decrease in malaria outbreaks in the first 6 months of the 18-month study.

Reaction Biology Corp. Awarded NIH SBIR Grant for Kinase Radioisotope Microarray Screening Development

MALVERN, Pa. (SEND2PRESS NEWSWIRE) — Reaction Biology Corporation (RBC) today announced that it has been awarded an SBIR grant from the National Cancer Institute to create a new kinase profiling and high throughput screening method using radioisotopes and microarrays. The $940,000 grant will be used to migrate the current well-plate radioisotope methods onto RBC’s DiscoveryDot nanoliter screening platform.

Epeius Biotechnologies Corporation Receives $400,000 Grant to Support Gene Therapy Trials for Pancreatic Cancer

SAN MARINO, CA – June 19 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today that the Company has been awarded a $400,000 grant by the Lazarex Cancer Foundation to expand and support ongoing cancer gene therapy clinical trials for advanced and metastatic pancreatic cancer.

MRSA: Addressing the Crisis

LOS ANGELES, CA – June 12 (SEND2PRESS NEWSWIRE) — The International Society of Microbial Resistance (ISMR) is focusing attention on MRSA by convening healthcare professionals to discuss the most current information on the rising prevalence and consequences of a family of antibiotic-resistant bacteria known as methicillin-resistant Staphylococcus aureus (MRSA).

Addressing the MRSA Crisis

HOUSTON, TX – June 2 (SEND2PRESS NEWSWIRE) — The International Society of Microbial Resistance (ISMR) is focusing attention, and educating healthcare professionals, on the rising prevalence and consequences of a relatively new family of antibiotic-resistant bacteria known as methicillin-resistant Staphylococcus aureus (MRSA), through a new 2006 MRSA Educational Summit Program. MRSA can cause serious infections in otherwise healthy newborns, children, and adults.

Key Organics Ltd and Reaction Biology Corporation Announce New Library Screening Format

CORNWALL, UK and MALVERN, PA – June 1 (SEND2PRESS NEWSWIRE) — Key Organics Ltd and Reaction Biology Corporation today announced that they have teamed up to provide a new library screening format to customers. Beginning this summer, the entire Key Bionet library of 37,500 diverse drug-like compounds will be offered for ‘rental’ screening on RBC’s DiscoveryDot(TM) platform. For the first time, customers will be able to screen the Key library without having to purchase it outright.

Interim HealthCare Inc. Names 2006 Interim HomeStyle Hero

SUNRISE, FL – May 30 (SEND2PRESS NEWSWIRE) — Interim HealthCare Inc., the nation’s largest provider of home health care and supplemental staffing, announced the winner of the national Interim HomeStyle Hero Award for 2006. Phyllis Dennis, Personal Care Assistant, from Greenville, South Carolina was the recipient of the national award which recognizes a home health aide who best represents the character traits that make up a hero such as honesty, experience, integrity and dependability. As the winner, she receives a $500 award.

The Future of IVF: Genetic Infertility Testing Breakthroughs Hold the Promise of Higher IVF Pregnancy Rates and Lower Multiple Birth Rates

DALLAS, TX – May 22 (SEND2PRESS NEWSWIRE) — Several breakthroughs in the field of In Vitro Fertilization (IVF), soon to be available in Texas exclusively at the Sher Institute for Reproductive Medicine (SIRM-Dallas), could dramatically increase the odds of a woman getting pregnant through IVF, while at the same time reducing the likelihood of multiple births.

Detroit Area Cosmetic Surgeon is the First to Offer New Non-Surgical Eye Procedure to Lift Drooping Eyelids, Soften Fine Lines and Crow’s Feet

DETROIT, MI – May 17 (SEND2PRESS NEWSWIRE)– Eyes by Thermage(TM), is a non-invasive eye area procedure that was recently introduced, following a multi-center study that produced excellent outcomes and patient satisfaction; Mark Berkowitz, MD., Medical Director of Accents Cosmetic Surgery and Medical Spa in Sterling Heights, MI, is the first practitioner in the area to complete the training and offer the procedure to patients.

The Not-A-Bottle(TM) Container System Can Help Hydrate the Sick and Elderly

ESTES PARK, CO – May 15 (SEND2PRESS NEWSWIRE) — Rocky Mountain Patents, LLC today announced that its innovative Not-A-Bottle(TM) container system can greatly assist in providing sufficient hydration to the sick and elderly. Dehydration is a significant cause of hospitalization for over one million elderly annually.

PHSN Limited and Enterprising Vision Inc. (EVI) forge an alliance to launch EVI’s Patient Adherence Communications Platform – MemoText

TORONTO, ON Canada – May 8 (SEND2PRESS NEWSWIRE) — EVI, (a global development firm specializing in information systems analysis, design and management) and PHSN, (Canada’s premier waiting room network) are pleased to announce a strategic alliance designed to facilitate improved patient adherence rates across the healthcare spectrum.

New Technology in Treating Chronic Sinus Infections Performed in Texas by San Antonio Physician

SAN ANTONIO, Texas, Apr. 18, 2006 (SEND2PRESS NEWSWIRE) — Dr. Anthony P. Sertich II of San Antonio, Texas is one of the first physicians in Texas to offer a new, minimally invasive technology for treating chronic sinus inflammation. The Balloon Sinuplasty(TM) system uses a small catheter and balloon to quickly open and expand blocked sinuses. To date Dr. Sertich has treated over 40 individuals successfully, and many more are in line to receive the balloon sinuplasty procedure.

Expanded Access Program for Rexin-G Provides Genetic Medicine to Cancer Patients, First Revenues for Epeius Biotechnologies

SAN MARINO, CA – Apr. 7 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today that the Philippine Bureau of Food and Drugs (BFAD) has approved an Expanded Access Program for Rexin-G(TM), the lead product of Epeius Biotechnologies, developed for the treatment of metastatic cancer. Following the landmark approval of Rexin-G(TM) for the treatment of all solid tumors, the Expanded Access Program extends the clinical applications of the world’s first targeted genetic medicine to many more cancer patients and enables Epeius Biotechnologies to recoup some of the costs of its ongoing clinical trials in Manila.

Epeius Biotechnologies Establishes Corporate Headquarters in San Marino, California – Facilities Include a Clinical Research Unit Dedicated to Evaluating New Genetic Medicine for Cancer

SAN MARINO, CA – Apr. 4 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today the establishment of its main corporate headquarters in San Marino, California. The specialty pharmaceutical company has been granted Orphan Drug Status by the FDA for its lead product Rexin-G(TM), an innovative anti-cancer agent that seeks out and destroys metastatic disease. Rexin-G(TM) has been tested in a wide variety of cancer types, including pancreatic cancer, breast cancer, colon cancer, uterine cancer, laryngeal cancer, smooth muscle cancer (leiomyosarcoma) and skin cancer (malignant melanoma).

Reaction Biology Corp. Awarded NIH R01 Screening Roadmap Grant for Microarray Screening Development

MALVERN, PA – Mar. 13 (SEND2PRESS NEWSWIRE) — Reaction Biology Corporation (‘RBC’) today announced that it has been awarded an R01 grant from the National Institutes of Health to accelerate development of its new DiscoveryDot(TM) High Throughput Screening technology for drug discovery. The NIH grant is part of the Screening Roadmap, designed to produce innovative chemical tools for use in biological research and drug development. Out of 8 recipients of grants pursuant to the original RFA, Reaction Biology is the only private corporation to be so awarded.

STC Clients Reach 100 Million Combined Vaccination Records

TUCSON, AZ – Mar. 1 (SEND2PRESS NEWSWIRE) — Scientific Technologies Corporation (STC), a leading provider of public health information technology solutions, announces the collection of the 100 millionth vaccination record by the eight states and one regional immunization management systems (IMS) supported by STC. The award winning IMS effectively reduces health care costs, protects the public health, and can assist in emergency response efforts as evidenced after Hurricane Katrina hit the Gulf Coast.

PreViser and OralCare Corporation Partner in Japan to Provide Oral Disease Risk Assessment

MOUNT VERNON, WA – Feb. 27 (SEND2PRESS NEWSWIRE) — PreViser Corporation, a Washington State-based provider of patented oral disease and risk assessment software technology to the dental industry, announced today the finalization of a licensing agreement with OralCare Corporation of Tokyo, Japan to market PreViser technology to dentists within Japan.

Clinical Study Confirms Safety and Efficacy of Novel Germicidal Device to Help Prevent Hospital-Acquired Infections

BOSTON, MA – Feb. 22 (SEND2PRESS NEWSWIRE) — Catheter site infections are among the most common and serious hospital-acquired infections. UVSolutions announces that data from a recently completed clinical study confirms its patented catheter site disinfection system (also patented for wound care) is safe and efficacious on the most sensitive skin.

PreViser and Delta Chakir partner in Israel to Provide Oral Disease Risk Assessment

MOUNT VERNON, WA – Jan. 31 (SEND2PRESS NEWSWIRE) — PreViser Corporation, a Washington State-based provider of patented oral disease risk assessment software technology to the dental industry, announced today the finalization of a licensing agreement with Delta Chakir, Ltd., sole distributor for Kodak Dental System in Israel, to market PreViser technology to dentists and dental insurers within Israel.

Most Dangerous Trends Facing Hospitals – What’s Wrong Here? In America, Flying is Safer Than Being Treated in a Hospital

MEMPHIS, TN – Jan. 24 (SEND2PRESS NEWSWIRE) — According to LifeWings Partners LLC, a recent survey of medical errors published in Health Affairs reveals that 34% of U.S. patients with critical health problems experience medical mistakes. Furthermore, this error rate was the highest among the six developed nations studied (United States, Canada, Australia, New Zealand, Germany, and U.K.). For 20% of the patients, communication between patients and hospital staff was a factor when errors occurred.